Evaluate the efficacy of Arjunadi lepa and Naturopathy based face mud pack in vyanga.
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2022/06/042971
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients suffering from classical clinical signs and symptoms of Vyanga
2. Patient of age 20 to 40 years irrespective of sex and religion
1.Patients receiving hormone or corticosteroid therapy
2.Patients with history of endocrine disorders or allergies.
3.Patients taking depigmenting or whitening products (oral or topical) within the previous 6 weeks.
4.Pregnant or breast feeding mother
5.Subjects who are allergic to chemical compound in the Lepa or fragrance.
6.Using a medication that increases sensitivity to sunlight including doxycycline, minocycline, tetracycline, ciprofloxin, hydrochlorothiazide, and sulfonamides.
7.Usage of any new skincare products during the course of the study.
8.Facial/laser treatment within the last 3 months
9.Facial cosmetic surgery within the last 12 months
10.Physical skin conditions such as excessive hair, scarring, tattoos that might impair evaluations of the test sites
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Melasma Area and Severity Index (MASI) Score <br/ ><br>Severity of melasma in each of the four regions (forehead, right malar region, left malar region and chin) is assessed on percentage of the total area involved (A), darkness (D), and homogeneity (H). <br/ ><br>Timepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method 1. Color assessment of facial hyperpigmentation <br/ ><br>2. Patients Global Assessment of facial hyperpigmentation <br/ ><br>3. Dermatology life quality indexTimepoint: 8 weeks